Yanhua Smartech Group to acquire 45% stake in Beijing Taihekang Medical Bio-Technology

Yanhua Smartech Group plans to buy a 45% stake in Beijing Taihekang Medical Bio-Technology, a supplier of in-vitro diagnosis products to Abbott Laboratories, for CNY 184.5 million (USD 26.2 million).

“Yanhua Smartech Group plans to buy a 45 percent share of a Chinese firm that supplies in-vitro diagnosis products to Abbot Laboratories as it looks expand its portfolio of services.”yicaiglobal.com

• 1 source
• yicaiglobal.comYanhua Smartech to Take 45% Stake in Abbot Laboratories IVD SupplierTang ShihuaNov 1, 2019

Summarized from public sources; check the original articles before acting on it.